- Open Access
Correction to: Prognostic assessment for patients with cancer and incidental pulmonary embolism
© The Author(s). 2018
- Received: 6 April 2018
- Accepted: 6 April 2018
- Published: 18 April 2018
The original article was published in Thrombosis Journal 2018 16:8
- 1)Within Table 1, under the sub-heading “Setting”, the numbers for the categories “Radical/adjuvant” and “Metastatic/incurable” were erroneously inversed. The correct numbers are:
Radical/adjuvant: 20 (46)
Metastatic/incurable: 80 (188)
In Table 3, the values in the HR(95%CI) column were misaligned in the WCC rows; The value “1” should be aligned with the <11.3x109 row and the value 1.1 (.7, 1.8) should be aligned with the >11.3x109 row.
Also in Table 3, within the OS (95%CI) column and under the subheading “Metastatic/incurable disease”, the value “10.5 (7.3, 13.7)” was misaligned and should be aligned with the “Yes” row.
Tables 1 and 3 have now been updated in the original article.
In the “Acknowledgements” section, the Fig. 1 legend “Survival curves for the Hull5 score groups for the first 12 months of follow-up. Line separators for the 30-day, 3-month, 6-month cut-offs and the median for survival are included”, was inserted in error.
Furthermore, for additional clarity, where the term “Vascular Thromboembolic Event” is used in the text, the reader is advised to read “Venous Thromboembolic Event” .
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.